BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 9224380)

  • 1. Multifocality in Testicular Cancer: Clinicopathological Correlations and Prognostic Implications.
    Bumbasirevic U; Petrovic M; Zekovic M; Coric V; Milojevic B; Lisicic N; Obucina D; Vasilic N; Bulat P; Zivkovic M; Cekerevac M; Bojanic N; Janicic A
    Life (Basel); 2024 Feb; 14(2):. PubMed ID: 38398766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of whole slide imaging-based deep learning in the assessment of intraoperative and postoperative sections in neuropathology.
    Shi L; Shen L; Jian J; Xia W; Yang KD; Tian Y; Huang J; Yuan B; Shen L; Liu Z; Zhang J; Zhang R; Wu K; Jing D; Gao X
    Brain Pathol; 2023 Jul; 33(4):e13160. PubMed ID: 37186490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of clinical stage I non-seminoma.
    Winter C; Hiester A
    Asian J Urol; 2021 Apr; 8(2):161-169. PubMed ID: 33996471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining a New Prognostic Index for Stage I Nonseminomatous Germ Cell Tumors Using CXCL12 Expression and Proportion of Embryonal Carcinoma.
    Gilbert DC; Al-Saadi R; Thway K; Chandler I; Berney D; Gabe R; Stenning SP; Sweet J; Huddart R; Shipley JM
    Clin Cancer Res; 2016 Mar; 22(5):1265-73. PubMed ID: 26453693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of retroperitoneal lymphadenectomy for germ cell cancer].
    Krege S
    Urologe A; 2009 Jan; 48(1):32-6. PubMed ID: 19066838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of relapse after lymph node dissection for germ cell tumours: can salvage chemotherapy be avoided?
    Berney DM; Shamash J; Hendry WF; Arora A; Jordan S; Oliver RT
    Br J Cancer; 2001 Feb; 84(3):340-3. PubMed ID: 11161398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors.
    Böhlen D; Borner M; Sonntag RW; Fey MF; Studer UE
    J Urol; 1999 Apr; 161(4):1148-52. PubMed ID: 10081858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of biological prognostic factors on therapy of non-seminomatous stage I testicular tumors--an assessment of the current status].
    Kuczyk MA; Bokemeyer C; Serth J; Machtens S; Höfner K; Jonas U
    Urologe A; 1996 Jan; 35(1):35-45. PubMed ID: 8851847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis.
    Heidenreich A; Sesterhenn IA; Mostofi FK; Moul JW
    Cancer; 1998 Sep; 83(5):1002-11. PubMed ID: 9731905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MIB-1 immunohistochemistry in clinical stage I nonseminomatous testicular germ cell tumors predicts patients at low risk for metastasis.
    Albers P; Bierhoff E; Neu D; Fimmers R; Wernert N; Müller SC
    Cancer; 1997 May; 79(9):1710-6. PubMed ID: 9128986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percentage of embryonal carcinoma and of vascular invasion predicts pathological stage in clinical stage I nonseminomatous testicular cancer.
    Moul JW; McCarthy WF; Fernandez EB; Sesterhenn IA
    Cancer Res; 1994 Jan; 54(2):362-4. PubMed ID: 8275469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor proliferative activity is predictive of pathological stage in clinical stage A nonseminomatous testicular germ cell tumors.
    Albers P; Ulbright TM; Albers J; Miller GA; Orazi A; Crabtree WN; Baniel J; Reister T; Sidner RA; Foster RS; Donohue JP
    J Urol; 1996 Feb; 155(2):579-86. PubMed ID: 8558664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New parameters for prediction of pathological stage in clinical stage I non-seminomatous testicular tumors].
    Albers P; Ulbright TM; Albers J; Miller GA; Foster RS; Donohue JP
    Urologe A; 1995 Jul; 34(4):316-23. PubMed ID: 7676541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical expression of Ki-67 to predict lymph node involvement in clinical stage I nonseminomatous germ cell tumors.
    Heidenreich A; Schenkmann NS; Sesterhenn IA; Mostofi FK; McCarthy WF; Heidenreich B; Moul JW
    J Urol; 1997 Aug; 158(2):620-5. PubMed ID: 9224380
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.